Confirmed objective responses were observed at 8.6 and 10 mg/kg q3w, with a high overall disease control rate in late-line metastatic colorectal cancer. Progression-free survival estimates near 7 ...
Zacks Investment Research on MSN
AstraZeneca's Imfinzi secures approval for gastric cancer in the EU
AstraZeneca AZN announced that the European Commission (EC) has approved its blockbuster cancer drug Imfinzi (durvalumab) as a perioperative treatment for early gastric and gastroesophageal junction ...
The American Cancer Society estimates that over 55,000 people will die from colorectal cancer in the U.S. this year. Of those ...
AstraZeneca’s Imfinzi in combo with standard-of-care FLOT chemotherapy gets European approval to treat patients with early gastric and gastroesophageal cancers: Cambridge, UK Tu ...
Givastomig is designed to simultaneously target CLDN18.2 and 4-1BB. CLDN18.2 is a tight junction protein that is typically ...
Good news: cancer death rates in the UK have fallen to their lowest level on record. According to the latest statistics from Cancer Research UK, between 2022 and 2024, around 247 people per 100,000 ...
AstraZeneca has received approval from the European Commission for the use of Imfinzi (durvalumab) in combination with FLOT chemotherapy as a perioperative treatment for adults with resectable ...
AstraZeneca's cancer immunotherapy Imfinzi has been approved in the EU for use before and after surgery for early-stage ...
Imfinzi (durvalumab), in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel), has received EU approval. The perioperative immunotherapy was ...
Head and neck cancer (HNC) represents a significant global health challenge, characterized by aggressive local invasion, frequent recurrence, and poor survival rates. Beyond its physical burden, HNC ...
On Mother’s Day, Clare Berry describes how her husband and two daughters carried her through eight months of dealing with cancer and reveals the unexpected positives that came out of her diagnosis ...
At 47 years old, orthopedic surgeon Todd Grunander never expected to hear the word cancer, let alone colon cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results